NWP-0476

Modify Date: 2024-01-13 19:19:53

NWP-0476 structure	Common Name	NWP-0476
	CAS Number	2290611-26-4	Molecular Weight	925.49
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₄₇H₅₃ClN₈O₈S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of NWP-0476

NWP-0476 is BCL-2/BCL-xL inhibitor. NWP-0476 has a modified structure with fine-tuned BCL-xL activity. NWP-0476 can be used for relapsed T-acute lymphoblastic leukemia (T-ALL) research[1].

Name	NWP-0476

Description	NWP-0476 is BCL-2/BCL-xL inhibitor. NWP-0476 has a modified structure with fine-tuned BCL-xL activity. NWP-0476 can be used for relapsed T-acute lymphoblastic leukemia (T-ALL) research[1].
Related Catalog	Signaling Pathways >> Apoptosis >> Bcl-2 Family Research Areas >> Neurological Disease
References	[1]. Saygin C, et al. Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia. Clin Cancer Res. 2023 Aug 15;29(16):3151-3161.

Molecular Formula	C₄₇H₅₃ClN₈O₈S
Molecular Weight	925.49

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3

NWP-0476

Use of NWP-0476

Names

NWP-0476 Biological Activity

Chemical & Physical Properties